Glioblastoma Multiforme (GBM) Archives

New Blood Test Could Detect Brain Cancers Earlier

ATR-FTIR Spectroscopy, Blood Tests, Brain Cancer, Brain Tumors, Glioblastoma Multiforme (GBM), Liquid Biopsies, Machine Learning, Nature Communications, Spectroscopy

Researchers at the University of Strathclyde in Glasgow, Scotland, potentially developed a blood test for brain cancer using high-throughput attenuated total reflection (ATR)-Fourier transform infrared (FTIR) spectroscopy with machine learning.

AbbVie Cuts 178 Stemcentrx Employees Months After Rova-T Failure

Advanced small-cell lung cancer, Business, Clinical Trials, Colorectal Cancer, Glioblastoma Multiforme (GBM), Hematology, Job Cuts, Metastatic Melanoma, Oncology, Pancreatic Cancer, Prostate Cancer, R&D

AbbVie is slashing 178 jobs from the company’s Stemcentrx subsidiary in South San Francisco.

FDA Orphan Drug Designation Granted to TTAC-0001

Biotech, FDA/Regulatory, Glioblastoma Multiforme (GBM), Orphan Drug Designation

The U.S. Food and Drug Administration granted orphan drug designation to PharmAbcine Inc.’s leading clinical compound TTAC-0001 for the treatment of glioblastoma multiforme.